Free Trial

Lineage Cell Therapeutics (LCTX) SEC Filings & 10K Form

Lineage Cell Therapeutics logo
$1.01 -0.01 (-0.98%)
As of 07/3/2025 05:00 PM Eastern

Recent Lineage Cell Therapeutics SEC Filings

DateFilerForm TypeView
07/02/2025
8:00 PM
ANDREWS DEBORAH J (Reporting)
Lineage Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
8:00 PM
Lineage Cell Therapeutics (Issuer)
Mulroy Michael H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
8:00 PM
Lineage Cell Therapeutics (Issuer)
Russell Angus C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
8:00 PM
Jayasuriya Anula (Reporting)
Lineage Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
8:00 PM
Amin Dipti (Reporting)
Lineage Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
8:26 AM
Lineage Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
4:00 PM
Lineage Cell Therapeutics (Filer)
Form DEFA14A
06/09/2025
4:25 PM
Lineage Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
8:09 AM
Lineage Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
3:15 PM
Lineage Cell Therapeutics (Filer)
Form ARS
04/24/2025
7:48 AM
BlackRock, Inc. (Filed by)
Lineage Cell Therapeutics (Subject)
Form SCHEDULE 13G
03/12/2025
4:30 PM
Lineage Cell Therapeutics (Issuer)
Samuel George A. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
4:30 PM
Howe Jill Ann (Reporting)
Lineage Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
4:30 PM
Culley Brian M (Reporting)
Lineage Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
3:15 PM
Lineage Cell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/28/2025
7:07 PM
BROADWOOD PARTNERS, L.P. (Filed by)
Lineage Cell Therapeutics (Subject)
Form SCHEDULE 13D/A
01/28/2025
6:49 PM
BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
Lineage Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Lineage Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
3:30 PM
Lineage Cell Therapeutics (Filer)
Form DEF 14A
11/29/2024
3:30 PM
Lineage Cell Therapeutics (Filer)
Form PRE 14A
11/26/2024
3:55 PM
Lineage Cell Therapeutics (Issuer)
Samuel George A. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
3:58 PM
Howe Jill Ann (Reporting)
Lineage Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
8:00 AM
Culley Brian M (Reporting)
Lineage Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
7:05 PM
BROADWOOD PARTNERS, L.P. (Filed by)
Lineage Cell Therapeutics (Subject)
Form SC 13D/A
11/21/2024
7:55 AM
Lineage Cell Therapeutics (Filer)
Form 424B5
11/20/2024
4:08 PM
Lineage Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Lineage Cell Therapeutics (Subject)
Form SC 13G
08/19/2024
5:24 PM
Howe Jill Ann (Reporting)
Lineage Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:00 PM
BRADSHER NEAL C (Reporting)
Lineage Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSEAMERICAN:LCTX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners